11/17/2026 | Press release | Distributed by Public on 11/17/2026 16:43
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| 10% Secured Convertible Note | $5 | 03/11/2026 | A | 50,000(1) | 03/11/2026 | 03/11/2029 | Common Stock | 10,000 | $50,000(2) | 50,000 | D | ||||
| Warrant (right to buy) | $7.5 | 03/11/2026 | A | 10,000(4) | 03/11/2026 | 03/11/2029 | Common Stock | 10,000 | $ 0 (2) | 10,000 | D | ||||
| 10% Secured Convertible Note | $5 | 05/29/2026 | D | 50,000(5) | 03/11/2026 | 03/11/2029(3) | Common Stock | 10,000 | (5) | 0 | D | ||||
| 10% Secured Convertible Note | $3 | 05/29/2026 | A | 50,000(5) | 05/29/2026 | 03/11/2029(3) | Common Stock | 16,667 | (5) | 50,000 | D | ||||
| Warrant (right to buy) | $7.5 | 05/29/2026 | D | 10,000(5) | 03/11/2026 | 03/11/2029 | Common Stock | 10,000 | (5) | 0 | D | ||||
| Warrant (right to buy) | $4.5 | 05/29/2026 | A | 16,667(5) | 05/29/2026 | 03/11/2029 | Common Stock | 16,667 | (5) | 16,667 | D | ||||
| 10% Secured Convertible Note | $3 | 11/02/2026 | A | 25,000(1) | 11/02/2026 | 11/02/2029(3) | Common Stock | 8,333 | $25,000(2) | 25,000 | D | ||||
| Warrant (right to buy) | $4.5 | 11/02/2026 | A | 8,333(4) | 11/02/2026 | 11/02/2029 | Common Stock | 8,333 | $ 0 (2) | 8,333 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Pawloski James C/O 374WATER INC 100 SOUTHCENTER COURT SUITE 200 MORRISVILLE, NC 27560 |
X | |||
| /s/ James Pawloski | 11/17/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The reporting person acquired the Issuer's 10% Secured Convertible Notes (the "Notes") and the related common stock purchase warrants (the "Warrants") from the Issuer in a private placement. The reporting person's participation was approved in advance by the Issuer's Board of Directors, and the acquisition is exempt under Rule 16b-3(d). The Notes are reported by principal amount. |
| (2) | The Notes were purchased at 100% of their principal amount. The Warrants were issued together with the Notes for no separate consideration. |
| (3) | The Notes bear interest at 10% per annum and are convertible, at the holder's option, into common stock at any time before the close of business on the third scheduled trading day preceding the maturity date, which is three years from the date of issuance. The number of underlying shares is the principal amount divided by the conversion price, rounded to the nearest whole share, and excludes accrued and unpaid interest, which is also convertible at the conversion price. On September 30, 2026, $2,780.82 of deferred interest was added to the principal amount of the Note issued on March 11, 2026; that amount is not included in the principal amount or underlying shares reported above. |
| (4) | The Warrants are exercisable for cash only, beginning on the date of issuance and expiring three years thereafter. The number of Warrant shares equals 100% of the shares underlying the related Note, rounded to the nearest whole share. |
| (5) | On May 29, 2026, the Issuer amended all outstanding Notes and Warrants issued in the private placement, on the same terms for all holders, to reduce the conversion price of the Notes from $5.00 to $3.00 per share, to reduce the exercise price of the Warrants from $7.50 to $4.50 per share, and to increase the number of shares issuable under each Warrant to maintain 100% coverage of the shares underlying the related Note (for the reporting person, from 10,000 to 16,667 shares). No additional consideration was paid. The amendment was approved by the Issuer's Board of Directors and is reported as the deemed cancellation of the original Note and Warrant and the acquisition of the amended Note and Warrant, exempt under Rule 16b-3(e) and Rule 16b-3(d), respectively |